| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.770 | 38.376 | 35.160 | 34.627 | 34.141 | 38.926 | 33.879 | 26.194 | 72.046 | 70.153 |
| Total Income - EUR | 43.774 | 39.046 | 36.479 | 34.634 | 34.150 | 39.036 | 49.861 | 60.967 | 72.057 | 70.165 |
| Total Expenses - EUR | 35.969 | 38.526 | 42.052 | 31.467 | 31.651 | 28.316 | 33.602 | 53.611 | 54.682 | 58.726 |
| Gross Profit/Loss - EUR | 7.805 | 520 | -5.573 | 3.167 | 2.499 | 10.721 | 16.259 | 7.356 | 17.375 | 11.439 |
| Net Profit/Loss - EUR | 6.484 | 136 | -5.925 | 2.821 | 2.165 | 10.459 | 16.017 | 7.099 | 16.679 | 10.193 |
| Employees | 4 | 3 | 4 | 3 | 3 | 2 | 3 | 4 | 4 | 4 |
Check the financial reports for the company - Codrea-Rovetmedis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 397 | 974 | 3.573 | 2.297 | 1.079 | 922 |
| Current Assets | 57.576 | 24.616 | 18.336 | 20.105 | 21.663 | 31.073 | 43.863 | 28.553 | 17.830 | 12.647 |
| Inventories | 0 | 230 | 154 | 0 | 0 | 93 | 0 | 526 | 0 | 633 |
| Receivables | 25.954 | 11.271 | 9.922 | 7.799 | 6.552 | 6.429 | 4.007 | 0 | 96 | 2.071 |
| Cash | 31.622 | 13.114 | 8.260 | 12.306 | 15.111 | 24.551 | 39.856 | 28.028 | 17.734 | 9.943 |
| Shareholders Funds | 56.577 | 22.735 | 16.425 | 18.945 | 20.743 | 30.808 | 46.143 | 28.646 | 16.268 | 10.288 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 999 | 1.881 | 1.911 | 1.160 | 1.317 | 1.239 | 1.293 | 2.205 | 2.641 | 3.281 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Codrea-Rovetmedis S.r.l.